IMAB.I-mab

Form 4: I-Mab Executive Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


📋All filings for I-mab

Sean Wuxiong Cao, Chief Bus. Development Officer of I-Mab, reported multiple transactions in common stock on September 3, 2026.

Summary

  • Option exercise/conversion: acquired 235,136 Ordinary Shares on September 3, 2026; holds 270,209 after (Direct).
  • Option exercise/conversion: acquired 104,236 Ordinary Shares on September 3, 2026; holds 374,445 after (Direct).
  • Option exercise/conversion: disposed of 102,233 Restricted Share Units on September 3, 2026; holds 306,700 after (Direct).
  • Option exercise/conversion: disposed of 45,320 Restricted Share Units on September 3, 2026; holds 135,960 after (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Sean Wuxiong Cao — Officer (Chief Bus. Development Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-09-03Option exercise/conversionOrdinary Shares235,136——270,209
2026-09-03Option exercise/conversionOrdinary Shares104,236——374,445
2026-09-03Option exercise/conversionRestricted Share Units102,233——306,700
2026-09-03Option exercise/conversionRestricted Share Units45,320——135,960

Key Dates

DateDescription
2026-09-03Option exercise/conversion (235,136 shares)
2026-09-03Option exercise/conversion (104,236 shares)
2026-09-03Option exercise/conversion (102,233 shares)
2026-09-03Option exercise/conversion (45,320 shares)

Keywords

insider transaction, Form 4, NBP, NovaBridge Biosciences, neutral, Sean Wuxiong Cao

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.